Andrzej Andraczke

Insider Reports History

Location
Houston, TX
Signature
/s/ Christopher Downs, Attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrzej Andraczke:

Company Role Class Num Shares Value Price $ Report Date Ownership
CNS Pharmaceuticals, Inc. Director Option to purchase common stock 45,428 21 Sep 2023 Direct

Insider Reports Filed by Andrzej Andraczke

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNSP CNS Pharmaceuticals, Inc. 21 Sep 2023 1 $0 4/A Director 12 Oct 2023, 18:00
CNSP CNS Pharmaceuticals, Inc. 15 Jul 2021 1 $0 4 Director 16 Jul 2021, 17:00